Breaking News

You are here » Indian-Commodity  :  Top News  :  Sun Pharma receives Australian TGA approval for ILUMYA

21-Sep2018

Sun Pharma receives Australian TGA approval for ILUMYA

Sun Pharmaceutical Industries has received the Australian Therapeutic Goods Administration (TGA) approval for its specialty product, ILUMYA (tildrakizumab) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.

ILUMYA selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL23 receptor leading to inhibition of the release of proinflammatory cytokines and chemokines. ILUMYA is administered at a dose of 100 mg by subcutaneous injection every 12 weeks after the completion of initial doses at weeks 0 and 4. ILUMYA is contraindicated in patients with a previous serious hypersensitivity reaction to tildrakizumab or to any of the excipients in ILUMYA, and in patients with clinically important active infections, e.g. active tuberculosis.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Related News

View all news

Barley futures surge on firm demand

Barley futures surged on NCDEX, as the participants widened their positions tracking firm demand from consuming industries. The contract for November delivery was trading at Rs 1880.00, up by......

Gold futures trade tad higher on Monday

Gold futures traded marginally higher on Monday, due to increased safe haven investments after the Asian stock markets tumbled in midst of increased geo-political tensions and on concerns over slowing......

Crude oil futures end higher on Friday

Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......

Top News

View all news

MPS reports 10% rise in Q2 consolidated net profit

MPS has reported results for second quarter ended September 30, 2018.The company has reported a rise of 8.55 % in its net profit of Rs 19.55 crore for the quarter under review as compared to Rs 18.01 crore......

Bhageria Industries reports around 3-fold jump in Q2 net profit

Bhageria Industries has reported results for second quarter ended September 30, 2018.The company has reported around 3-fold jump in its net profit at Rs 28.21 crore for the quarter under review as compared......

Gayatri Projects bags three new orders worth Rs 403.96 crore

Gayatri Projects has bagged three new orders worth Rs 403.96 crore from Bihar State Road Development Corporation (BSRDC). These projects will be executed on an EPC (Engineering, Procurement & Construction)......